Loftsson, T; Masson, M; Brewster, ME: Self-association of cyclodextrins and

Analysis of the molecular association of rifampicin. 51. LOFTSSON, T.; MASSON,

Thorsteinn Loftsson Corresponding Author Contact Information . .. Masson et al.,

[14].Thompson DO. Crit Rev Ther Drug Carrier. Syst.1997;14:1-104. [15].Masson

recent review of the available data, Loftsson and Masson concluded that the

[23] Loftsson T, Masson M, Brewster ME. Self-association of cyclodextrins and

Loftsson T, Masson M: The effects of water-soluble polymers on cyclodextrins

3: Thorsteinsson T, Loftsson T, Masson M. Soft antibacterial agents. Curr Med

17: Thorsteinsson T, Masson M, Loftsson T. Dermal delivery of ETH-615, a

Loftsson, T., & Masson, M. (2001). Cyclodextrins in topical drug formulations:

11: Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and

Feb 17, 2004 . Loftsson, T., Másson, M. and Brewster, M. E. (2004), Self-association of . ..

Now you can keep track of the latest trends and developments .

Preservation.; Block S.S., Ed., p. 309, Lea &. Febiger, Philadelphia 1983. 10. (a)

Thorsteinsson T, Loftsson T, Masson M. 2003. Soft antibacterial agents. Curr Med

T. Loftsson, F. Konráðsdóttir and M. Másson . . 1999; Loftsson and Masson .

Feb 20, 2010 . Gudmundsdottir H, Sigurjonsdottir JF, Masson M, Fjalldal O, Stefansson E,

T. Loftsson, H. Fridriksdottir, G. Ingvarsdottir, B. Jonsdottir and A.M. . Loftsson et

Complexation propierties of B-cyclodextrin sulfobutylether sodium salt 359 T.

Drug/cyclodextrin/hydroxy acid multicomponent systems: properties and

Nov 9, 2006 . Loftsson T., Masson M., 2001. Cyclodextrins in topical drug formulations: theory

Apr 21, 2003 . Masson M, Loftsson T, Masson G, Stefansson E. Cyclodextrins as permeation

Thorsteinn Loftsson†, Pekka Jarho, Már Másson & Tomi Järvinen . . Used with

85: 1142-69. 63. Loftsson, T. & M.E. Brewster (1996) J. Pharm. Sci. 85: 1017-25.

Adv Anal Chem Instrum. 1965; 4: 117–212. [13] Loftsson T, Masson M, Brewster

Loftsson, T., Leeves, N., Sigurjonsdottir, J. F., Sigurosson, H. H., and Masson, M.

Masson, T. Loftsson and E. Stefansson, „Midazolam solubilized with

Loftsson, T.; Masson, M. Cyclodextrins in topical drug formulations: theory

Loftsson, T., Leeves, N., Bjornsdóttir, B., Duffy, L., Mason, M. (1999). Effect of

T. Thorsteinsson, M. Masson and T. Loftsson, „Dermal delivery of ETH-615, a

Sci., 75, 775–783. 9. Thorsteinsson, T., Loftsson,T., Masson, M. (2003). Soft

Jul 1, 2003 . Authors: Thorsteinsson T.; Loftsson T.; Masson M. Source: Current Medicinal

Int J Pharm. 2001. Review Cyclodextrins in topical drug formulations: theory and

Mar 19, 2010 . [2] (a)Thorsteinsson, T.; Loftsson, T.; Masson, M., Curr. Med.Chem., 2003, 10,

hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter.

Sci., 87, 891?900 (1998). 26) Loftsson T., Magn?sd?ttir A., Masson M., Sigurj?

2003: T Thorsteinsson; T Loftsson; M Masson Soft antibacterial agents. Current

Sigurjonsdottir JF, Loftsson T, and Masson M (1999) Influence of cyclodextrins on

Feb 24, 2011 .

Loftsson, T., Jarho, P., Masson, M., Jarvinen, T.: Cyclodextrins in drug delivery.

References. 1 Loftsson T, Masson M . International Journal of Plwmlaceutics ,

Jul 13, 2007 . Loftsson, T., Vogensen, S. B., Brewster, M. E. and Konráðsdóttir, F. (2007), Effects

Dec 5, 2003 . Gudmundsdottir H, Sigurjonsdottir JF, Masson M, Fjalldal O, Stefansson E,

Loftsson T and Brewster M. Cyclodextrins as Pharmaceutical Excipients. Phar-

H. H. Sigurðsson, E. Knudsen, T. Loftsson, N. Leeves, J. F. Sigurjonsdottir .

Thorsteinsson T, Loftsson T, Masson M. Faculty of Pharmacy, University of

cyclodextrins in the development of formulations for chemical delivery systems.

Loftsson T, Magnudottir A, Masson M, Sigurjonsdottir JF. Self-association and

In fact, Kruss et al,17 Loftsson,18 and Loftsson and Masson19 have filed patent

Masson M. Loftsson T, Masson G, Stefanson E. Cyclodextrins as permeation

Sitemap